The Global Neurology Academy (GNA) Series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Evaluating and Promoting Health in Idiopathic Hypersomnia: Beyond Sleepy
Evaluating and Promoting Health in Idiopathic Hypersomnia: Beyond Sleepy
Treatment Options for the Management of Narcolepsy
Treatment Options for the Management of Narcolepsy
Practical Approach to Incorporation of Oxybates Into Clinical Practice
Practical Approach to Incorporation of Oxybates Into Clinical Practice
Challenges in Recognizing and Diagnosing Narcolepsy
Challenges in Recognizing and Diagnosing Narcolepsy
The Role of S1P Receptor Agonists in MS: Strategies for Disease Management
The Role of S1P Receptor Agonists in MS: Strategies for Disease Management
What Do Clinicians Need To Know? Utilizing Clinically Validated Diagnostic Tools to Diagnose MS Earlier
What Do Clinicians Need To Know? Utilizing Clinically Validated Diagnostic Tools to Diagnose MS Earlier
From Prescription to Personalization: An HCP’s Guide to Tailoring MS Therapeutic Management
From Prescription to Personalization: An HCP’s Guide to Tailoring MS Therapeutic Management
Navigating the Diagnostic Maze: Strategies for Excluding MS Disease Mimics
Navigating the Diagnostic Maze: Strategies for Excluding MS Disease Mimics
Missed Opportunities in Multiple Sclerosis Care: Increasing HCP Awareness of Early Diagnostic Delays
Missed Opportunities in Multiple Sclerosis Care: Increasing HCP Awareness of Early Diagnostic Delays
Advancements in MRI Technology: Improved Diagnosis and Monitoring of MS
Advancements in MRI Technology: Improved Diagnosis and Monitoring of MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
